Lazard Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,445
| Closed | -$164K | – | 2475 |
|
|
2024
Q1 | $164K | Sell |
10,445
-539
| -5% | -$8.46K | ﹤0.01% | 1374 |
|
|
2023
Q4 | $177K | Buy |
10,984
+257
| +2% | +$4.14K | ﹤0.01% | 1435 |
|
|
2023
Q3 | $136K | Buy |
+10,727
| New | +$136K | ﹤0.01% | 1521 |
|
|
2023
Q2 | – | Sell |
-8,421
| Closed | -$130K | – | 2608 |
|
|
2023
Q1 | $130K | Buy |
+8,421
| New | +$130K | ﹤0.01% | 1435 |
|
|
2022
Q4 | – | Sell |
-3,761
| Closed | -$69K | – | 2608 |
|
|
2022
Q3 | $69K | Buy |
+3,761
| New | +$69K | ﹤0.01% | 1652 |
|
|
2022
Q2 | – | Sell |
-6,182
| Closed | -$57K | – | 2627 |
|
|
2022
Q1 | $57K | Buy |
+6,182
| New | +$57K | ﹤0.01% | 1678 |
|
|
2021
Q3 | – | Sell |
-1,739
| Closed | -$63K | – | 2331 |
|
|
2021
Q2 | $63K | Buy |
1,739
+714
| +70% | +$25.9K | ﹤0.01% | 1506 |
|
|
2021
Q1 | $45K | Buy |
+1,025
| New | +$45K | ﹤0.01% | 1489 |
|